CSIMarket
 
Septerna Inc   (NASDAQ: SEPN)
 
Price: $37.9700 $0.60 1.606%
Day's High: $39.400001525878906 Week Perf: 1.25 %
Day's Low: $ 37.15 30 Day Perf: -2.27 %
Volume (M): 475,286 52 Wk High: $ 51.10
Volume (M$): $ 0 52 Wk Avg: $27.79
Open: $37.15 52 Wk Low: $13.67



 Market Capitalization (Millions $) 1,710
 Shares Outstanding (Millions) 45
 Employees 130
 Revenues (TTM) (Millions $) 99
 Net Income (TTM) (Millions $) -24
 Cash Flow (TTM) (Millions $) -118
 Capital Exp. (TTM) (Millions $) 1

Business Description


The company conducts research and development of product candidates, including the SEP-479 and SEP-631 programs, with a focus on therapeutic benefits and clinical trials. It collaborates with Novo Nordisk A/S to develop and commercialize potential oral small molecule therapies for metabolic-related diseases, including obesity and type 2 diabetes, utilizing its proprietary Native Complex Platform® and associated intellectual property rights.


   Company Address: 250 East Grand Avenue South San Francisco 94080 CA
   Company Phone Number: 338-3533   Stock Exchange / Ticker: NASDAQ SEPN


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
• View Complete Report
   



Partnership

Strategic Alliance in Pharmaceutical Innovation Septerna Collaborates with Novo Nordisk on Metabolic Disease Therapie...

Published Fri, May 16 2025 4:24 PM UTC

Significant Advances in Metabolic Disease Treatment: Septerna s Strategic Alliance with Novo Nordisk Septerna Inc. (NASDAQ: SEPN), a company committed to pioneering advancements in pharmaceutical sciences, has marked a significant milestone in its business trajectory with the announcement of a strategic global collaboration with Novo Nordisk. This partnership aims to develo...




Fundamental Analysis

Valuation Current
Price to Earnings PE Ratio (TTM) -
Price to Earnings PE Ratio (Expected) -
Price to Sales (TTM) 17.30
Price to Sales (Expected) -
Price to Book 4.42
PEG (TTM) -

Financial Strength Current
Quick Ratio 4.69
Working Capital Ratio 4.99
Leverage Ratio (MRQ) 0.47
Total Debt to Equity -
Interest Coverage (TTM) -
Debt Coverage (TTM) -

Per Share Current
Earnings (TTM) -0.54 $
Revenues (TTM) 2.2 $
Cash Flow (TTM) -
Cash 8.27 $
Book Value 8.59 $
Dividend (TTM) 0 $

Efficiency Current
Revenue per Employee (TTM) 760,631
Net Income per Employee (TTM) -186,431
Receivable Turnover Ratio (TTM) 9.42
Inventory Turnover Ratio (TTM) -
Asset Turnover Ratio (TTM) 0.17

Profitability Ratios Current
Gross Margin (MRQ) 0 %
Operating Margin (MRQ) -62.95 %
Net Margin (MRQ) -48.73 %
Net Cash Flow Margin (MRQ) 0 %
Effective Tax Rate (TTM) -

Management Effectiveness Current
Return On Assets (TTM) -
Return On Investment (TTM) -
Return On Equity (TTM) -
Dividend Yield -
Pay out Ratio (TTM) -



Septerna Inc's Segments





Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.